ALENT Fundamental Analysis - ETHERO

Fundamental Rating

Taking everything into account, ALENT scores 3 out of 10 in our fundamental rating. ALENT was compared to 18 industry peers in the Interactive Media & Services industry. While ALENT is still in line with the averages on profitability rating, there are concerns on its financial health. ALENT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALENT was profitable.

Of the past 5 years ALENT 4 years were profitable.

The reported operating cash flow has been mixed in the past 5 years: ALENT reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of 1.84%, ALENT is not doing good in the industry: 61.11% of the companies in the same industry are doing better.

ALENT's Return On Invested Capital of 14.66% is in line compared to the rest of the industry. ALENT outperforms 55.56% of its industry peers.

The Average Return On Invested Capital over the past 3 years for ALENT is significantly above the industry average of 20.88%.

The 3 year average ROIC (82.53%) for ALENT is well above the current ROIC(14.66%). The reason for the recent decline needs to be investigated.

		Industry Rank	Sector Rank
ROA	1.84%
ROE	N/A
ROIC	14.66%

ROA(3y)5.37%

ROA(5y)19.39%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)82.53%

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 8.45%, ALENT is in line with its industry, outperforming 44.44% of the companies in the same industry.

ALENT's Profit Margin has improved in the last couple of years.

ALENT has a Operating Margin (14.26%) which is in line with its industry peers.

In the last couple of years the Operating Margin of ALENT has declined.

		Industry Rank	Sector Rank
OM	14.26%
PM (TTM)	8.45%
GM	N/A

OM growth 3Y-5.86%

OM growth 5YN/A

PM growth 3Y-11.77%

PM growth 5Y33.49%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALENT is creating value.

ALENT has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for ALENT remains at a similar level compared to 5 years ago.

There is no outstanding debt for ALENT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -0.34, we must say that ALENT is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of ALENT (-0.34) is worse than 83.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-0.34

ROIC/WACC1.81

WACC8.08%

2.3 Liquidity

ALENT has a Current Ratio of 1.18. This is a normal value and indicates that ALENT is financially healthy and should not expect problems in meeting its short term obligations.

ALENT has a Current ratio of 1.18. This is in the lower half of the industry: ALENT underperforms 61.11% of its industry peers.

ALENT has a Quick Ratio of 1.18. This is a normal value and indicates that ALENT is financially healthy and should not expect problems in meeting its short term obligations.

ALENT has a Quick ratio (1.18) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.18
Quick Ratio	1.18

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 143.51% over the past year.

The Earnings Per Share has been growing by 40.85% on average over the past years. This is a very strong growth

ALENT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.68%.

ALENT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.57% yearly.

EPS 1Y (TTM)143.51%

EPS 3Y-23.13%

EPS 5Y40.85%

EPS Q2Q%-120.9%

Revenue 1Y (TTM)-23.68%

Revenue growth 3Y-12.89%

Revenue growth 5Y5.57%

Sales Q2Q%-18.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALENT is valuated quite expensively with a Price/Earnings ratio of 155.00.

ALENT's Price/Earnings ratio is a bit more expensive when compared to the industry. ALENT is more expensive than 72.22% of the companies in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 26.29, ALENT is valued quite expensively.

		Industry Rank	Sector Rank
PE	155
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALENT is valued a bit more expensive than 77.78% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	39.56

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)3.79

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALENT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ETHERO

EPA:ALENT (12/9/2025, 7:00:00 PM)

1.55

+0.08 (+5.44%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryInteractive Media & Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap5.95M

Revenue(TTM)558.40K

Net Income(TTM)47.20K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	155
Fwd PE	N/A
P/S	10.66
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	39.56

EPS(TTM)0.01

EY0.65%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS0.15

BVpS-0.01

TBVpS-0.01

PEG (NY)N/A

PEG (5Y)3.79

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	1.84%
ROE	N/A
ROCE	19.94%
ROIC	14.66%
ROICexc	N/A
ROICexgc	N/A
OM	14.26%
PM (TTM)	8.45%
GM	N/A
FCFM	N/A

ROA(3y)5.37%

ROA(5y)19.39%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)82.53%

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)112.29%

ROCE(5y)166.87%

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-5.86%

OM growth 5YN/A

PM growth 3Y-11.77%

PM growth 5Y33.49%

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.22

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	0
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.18
Quick Ratio	1.18
Altman-Z	-0.34

F-ScoreN/A

WACC8.08%

ROIC/WACC1.81

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)143.51%

EPS 3Y-23.13%

EPS 5Y40.85%

EPS Q2Q%-120.9%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-23.68%

Revenue growth 3Y-12.89%

Revenue growth 5Y5.57%

Sales Q2Q%-18.04%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-58.54%

EBIT growth 3Y-18%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y110.31%

FCF growth 3Y-17.99%

FCF growth 5YN/A

OCF growth 1Y111.62%

OCF growth 3Y-17.82%

OCF growth 5YN/A

ETHERO / ALENT.PA FAQ

What is the fundamental rating for ALENT stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALENT.PA.

What is the valuation status for ALENT stock?

ChartMill assigns a valuation rating of 0 / 10 to ETHERO (ALENT.PA). This can be considered as Overvalued.

Can you provide the profitability details for ETHERO?

ETHERO (ALENT.PA) has a profitability rating of 4 / 10.

What is the valuation of ETHERO based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ETHERO (ALENT.PA) is 155 and the Price/Book (PB) ratio is -167.66.

Can you provide the financial health for ALENT stock?

The financial health rating of ETHERO (ALENT.PA) is 3 / 10.

ETHERO (ALENT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ETHERO / ALENT.PA FAQ

What is the fundamental rating for ALENT stock?

What is the valuation status for ALENT stock?

Can you provide the profitability details for ETHERO?

What is the valuation of ETHERO based on its PE and PB ratios?

Can you provide the financial health for ALENT stock?